KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of GoodwillAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Teladoc Health (TDOC) Change in Inventory (2020 - 2025)

Teladoc Health (TDOC) has disclosed Change in Inventory for 6 consecutive years, with -$1.4 million as the latest value for Q4 2025.

  • Quarterly Change in Inventory fell 201.2% to -$1.4 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$399000.0 through Dec 2025, down 104.09% year-over-year, with the annual reading at -$399000.0 for FY2025, 104.09% down from the prior year.
  • Change in Inventory hit -$1.4 million in Q4 2025 for Teladoc Health, down from $1.9 million in the prior quarter.
  • In the past five years, Change in Inventory ranged from a high of $16.8 million in Q4 2021 to a low of -$10.6 million in Q2 2023.
  • Historically, Change in Inventory has averaged -$502550.0 across 5 years, with a median of -$108000.0 in 2021.
  • Biggest five-year swings in Change in Inventory: crashed 1447.59% in 2022 and later surged 236.43% in 2023.
  • Year by year, Change in Inventory stood at $16.8 million in 2021, then crashed by 106.48% to -$1.1 million in 2022, then tumbled by 436.11% to -$5.8 million in 2023, then soared by 124.29% to $1.4 million in 2024, then plummeted by 201.2% to -$1.4 million in 2025.
  • Business Quant data shows Change in Inventory for TDOC at -$1.4 million in Q4 2025, $1.9 million in Q3 2025, and $654000.0 in Q2 2025.